why choose us

First received: May 30, 2023

Clinical Trial: Symptom-inhibited Fentanyl Induction

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Opioid Use Disorder

Study Type: INTERVENTIONAL


Official Title: Rapid IV Symptom-inhibited Fentanyl Induction (SIFI) to Facilitate Rotation Onto Oral Opioid Agonist Therapy (OAT)

Brief Summary: The goal of this clinical trial is to test a treatment strategy for individuals with opioid use disorder (OUD) who use fentanyl.Participants will receive medically-administered doses of intravenous (IV) fentanyl at intervals until they are comfortable and do not have withdrawal symptoms.They then will be given opioid agonist therapy (OAT) once daily by mouth, which is the current standard treatment for OUD.In this trial, each participant's starting dose of OAT will be tailored to meet their opioid needs,…

Read more